Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Outside the Lab Oncology, Training and education, Regulation and standards, Histology, Clinical care

Not Reflective of Clinical Practice

Commenting in response to the JAMA article published in March 2015 on diagnostic concordance among pathologists interpreting breast biopsy specimens (1)…

Although the JAMA article (1) claims to have identified a lack of consistency in pathologists’ breast cancer diagnoses, this doesn’t reflect actual clinical practice, where the rate of discordance is significantly less. Pathologists are physicians and, as such, make diagnoses based on all available information, including clinical information, radiologic findings and all of the available pathology material. Communication with the submitting physician is common, as is confirmation of all malignant diagnoses by a second pathologist and a more comprehensive workup of atypical cases, including recuts, immunohistochemical stains and second opinions when necessary. This means that virtually all cases with a diagnosis of invasive cancer, DCIS or atypia are seen by more than one additional pathologist.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Kenneth Bloom

An early adopter of information technology, Kenneth developed the first commercial telepathology system during his residency. Creator of the Pathology Information System at Rush Medical Center, he also helped design the hospital’s Tumor Registry and Surgical Information System. His career spans more than 30 years, including key positions in start-up companies, University-based medical centers and commercial laboratories. An author of more than 50 peer-reviewed articles, he has also served as principal investigator of more than a dozen clinical trials. Currently, he is President and CEO of Clarient Pathology Services, and Chief Medical Officer of Clarient Diagnostic Services, where his lab evaluates over 100 breast cancers daily.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register